» Articles » PMID: 32161194

T Cell Response Kinetics Determines Neuroinfection Outcomes During Murine HSV Infection

Overview
Journal JCI Insight
Date 2020 Mar 13
PMID 32161194
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus-2 (HSV-2) and HSV-1 both can cause genital herpes, a chronic infection that establishes a latent reservoir in the nervous system. Clinically, the recurrence frequency of HSV-1 genital herpes is considerably less than HSV-2 genital herpes, which correlates with reduced neuronal infection. The factors dictating the disparate outcomes of HSV-1 and HSV-2 genital herpes are unclear. In this study, we show that vaginal infection of mice with HSV-1 leads to the rapid appearance of mature DCs in the draining lymph node, which is dependent on an early burst of NK cell-mediated IFN-γ production in the vagina that occurs after HSV-1 infection but not HSV-2 infection. Rapid DC maturation after HSV-1 infection, but not HSV-2 infection, correlates with the accelerated generation of a neuroprotective T cell response and early accumulation of IFN-γ-producing T cells at the site of infection. Depletion of T cells or loss of IFN-γ receptor (IFN-γR) expression in sensory neurons both lead to a marked loss of neuroprotection only during HSV-1, recapitulating a prominent feature of HSV-2 infection. Our experiments reveal key differences in host control of neuronal HSV-1 and HSV-2 infection after genital exposure of mice, and they define parameters of a successful immune response against genital herpes.

Citing Articles

Association between human herpes simplex virus and severe headache or migraine among aged 20-49 years: a cross-sectional study.

Zheng T, Jiang L, Li G, Zeng N, Yu B, Duan S Front Neurol. 2024; 15:1476863.

PMID: 39440252 PMC: 11493693. DOI: 10.3389/fneur.2024.1476863.


Vaginal lactobacilli produce anti-inflammatory β-carboline compounds.

Glick V, Webber C, Simmons L, Martin M, Ahmad M, Kim C Cell Host Microbe. 2024; 32(11):1897-1909.e7.

PMID: 39423813 PMC: 11694765. DOI: 10.1016/j.chom.2024.09.014.


Safety of non-replicative and oncolytic replication-selective HSV vectors.

Epstein A, Rabkin S Trends Mol Med. 2024; 30(8):781-794.

PMID: 38886138 PMC: 11329358. DOI: 10.1016/j.molmed.2024.05.014.


Tissue-specific features of innate lymphoid cells in antiviral defense.

Piersma S Cell Mol Immunol. 2024; 21(9):1036-1050.

PMID: 38684766 PMC: 11364677. DOI: 10.1038/s41423-024-01161-x.


Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology.

Smith J, Herbert J, Truong N, Cunningham A Front Immunol. 2022; 13:936235.

PMID: 36211447 PMC: 9538770. DOI: 10.3389/fimmu.2022.936235.


References
1.
Richards J, Kern E, Overall Jr J, Glasgow L . Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection. J Infect Dis. 1981; 144(5):464-71. DOI: 10.1093/infdis/144.5.464. View

2.
REEVES W, Corey L, ADAMS H, Vontver L, Holmes K . Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981; 305(6):315-9. DOI: 10.1056/NEJM198108063050604. View

3.
Szpara M, Gatherer D, Ochoa A, Greenbaum B, Dolan A, Bowden R . Evolution and diversity in human herpes simplex virus genomes. J Virol. 2013; 88(2):1209-27. PMC: 3911644. DOI: 10.1128/JVI.01987-13. View

4.
Lee S, Carrero J, Uppaluri R, White J, Archambault J, Lai K . Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1). J Immunol. 2013; 191(8):4223-34. PMC: 3874833. DOI: 10.4049/jimmunol.1300910. View

5.
Bernstein D, Cardin R, Bravo F, Awasthi S, Lu P, Pullum D . Successful application of prime and pull strategy for a therapeutic HSV vaccine. NPJ Vaccines. 2019; 4:33. PMC: 6671986. DOI: 10.1038/s41541-019-0129-1. View